News
Projects
Orgs
Project
Articles 7
Votes 0
Jnj.com

Authors 1

Tamekia Reece
FDA approval of ICOTYDE™ (icotrokinra) ushers in new era for first-line systemic treatment of plaque psoriasis with a targeted oral peptide - Johnson & Johnson
8d
Johnson & Johnson Expands U.S. Footprint with more than $1 Billion Investment in Next Generation Cell Therapy Manufacturing Facility in Pennsylvania - Johnson & Johnson
~1mo
Johnson & Johnson Submits OTTAVA™ Robotic Surgical System to the U.S. Food and Drug Administration - Johnson & Johnson
3mo
Johnson & Johnson Statement on the Phase 2b DUPLEX-AD Study - Johnson & Johnson
3mo
U.S. FDA Approval of RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) Enables the Simplest, Shortest Administration Time for a First-Line Combination Regimen when combined with LAZCLUZE® (lazertinib) - Johnson & Johnson
3mo
Johnson & Johnson Marks New Era as Global Healthcare Company with Updated Visual Identity - Johnson & Johnson
>2y
"As Black Men, We Keep Things Close to the Hip": 5 Questions for a Urologist About Prostate Cancer - Johnson & Johnson
~3y